458 results on '"Xie, Youhua"'
Search Results
102. The recombinant subunit vaccine RBD-Fc, consisting of SARS-CoV-2 RBD and human IgG Fc as an immunopotentiator, elicits robust neutralizing antibody responses against SARS-CoV-2 infection
103. A rapid and efficient screening system for neutralizing antibodies and its application for the discovery of potent neutralizing antibodies to SARS-CoV-2 S-RBD
104. Characterization of IL-21-expressing recombinant hepatitis B virus (HBV) as a therapeutic agent targeting persisting HBV infection
105. A novel intrahepatic restriction factor, HMGA1, contributes to hepatitis B virus (HBV) replication in immune tolerant phase, serving as an anti-HBV target
106. Human-IgG-Neutralizing Monoclonal Antibodies Block the SARS-CoV-2 Infection
107. Identification of Human Single-Domain Antibodies against SARS-CoV-2
108. Immunization with the receptor–binding domain of SARS-CoV-2 elicits antibodies cross-neutralizing SARS-CoV-2 and SARS-CoV without antibody-dependent enhancement
109. Protoporphyrin IX and verteporfin prevent SARS-CoV-2 infectionin vitroand in a mouse model expressing human ACE2
110. Functional and Genetic Analysis of Viral Receptor ACE2 Orthologs Reveals a Broad Potential Host Range of SARS-CoV-2
111. RETRACTED ARTICLE: SARS-CoV-2 infects T lymphocytes through its spike protein-mediated membrane fusion
112. Fully human single-domain antibodies against SARS-CoV-2
113. Combination immunotherapy with anti-PD-L1 antibody and depletion of regulatory T cells during acute viral infections results in improved virus control but lethal immunopathology
114. Recapitulation of SARS-CoV-2 Infection and Cholangiocyte Damage with Human Liver Organoids
115. In vitro biochemical and thermodynamic characterization of nucleocapsid protein of SARS
116. FRI-203-Inhibition of hepatitis B virus replication by FAM176A via activation of PI3K-AKT-mTOR signaling pathway
117. A dual-functional HER2 aptamer-conjugated, pH-activated mesoporous silica nanocarrier-based drug delivery system provides in vitro synergistic cytotoxicity in HER2-positive breast cancer cells
118. PS-075-AAV-delivered IL-21 activates CD8+ T-cells to clear HBV replicon plasmid and cccDNA in mice
119. FRI-203-Inhibition of hepatitis B virus replication by FAM176A via activation of PI3K-AKT-mTOR signaling pathway
120. Corrigendum: A Novel Phage PD-6A3, and Its Endolysin Ply6A3, With Extended Lytic Activity Against Acinetobacter baumannii
121. Establishment of an reporter system for screening HBx-targeting molecules
122. A Novel Phage PD-6A3, and Its Endolysin Ply6A3, With Extended Lytic Activity Against Acinetobacter baumannii
123. IL-21-based therapies induce clearance of hepatitis B virus persistence in mouse models
124. Proscillaridin A inhibits hepatocellular carcinoma progression through inducing mitochondrial damage and autophagy.
125. Quantitative Proteomic Analysis of Exosome Protein Content Changes Induced by Hepatitis B Virus in Huh-7 Cells Using SILAC Labeling and LC–MS/MS
126. Association of Mutations in Toll-like Receptor 2 Signaling Genes With Fulminant Form of Hepatitis B-Related Acute Liver Failure
127. PS-075-AAV-delivered IL-21 activates CD8+ T-cells to clear HBV replicon plasmid and cccDNA in mice
128. Identification of a Torque Teno Mini Virus (TTMV) in Hodgkin’s Lymphoma Patients
129. Copolymer micelles function as pH-responsive nanocarriers to enhance the cytotoxicity of a HER2 aptamer in HER2-positive breast cancer cells
130. Capable Infection of Hepatitis B Virus in Diffuse Large B-cell Lymphoma
131. Hepatitis B virus persistence in mice reveals IL-21 and IL-33 as regulators of viral clearance
132. ABCB5 promotes melanoma metastasis through enhancing NF-κB p65 protein stability
133. Synergistic Cytotoxicity of Lenalidomide and Dexamethasone in Mantle Cell Lymphoma via Cereblon-dependent Targeting of the IL-6/STAT3/PI3K Axis
134. Prox1 represses IL-2 gene expression by interacting with NFAT2
135. Hepatocyte nuclear factor 1α downregulates HBV gene expression and replication by activating the NF-κB signaling pathway
136. Hepatitis B virus X protein is capable of down-regulating protein level of host antiviral protein APOBEC3G
137. Unimpaired immunogenicity of yeast-expressed hepatitis B surface antigen stored at elevated temperatures
138. Establishment of an in vitro reporter system for screening HBx-targeting molecules.
139. Nuclear factor Y regulates ancient budgerigar hepadnavirus core promoter activity
140. Short-term intratracheal use of PEG-modified IL-2 and glucocorticoid persistently alleviates asthma in a mouse model
141. Efficient Inhibition of Hepatitis B Virus Infection by a preS1-binding Peptide
142. Engineering Hepadnaviruses as Reporter-Expressing Vectors: Recent Progress and Future Perspectives
143. Re-Designed Recombinant Hepatitis B Virus Vectors Enable Efficient Delivery of Versatile Cargo Genes to Hepatocytes with Improved Safety
144. Comparative Transcriptomic Analysis of Primary Duck Hepatocytes Provides Insight into Differential Susceptibility to DHBV Infection
145. A human monoclonal antibody against small envelope protein of hepatitis B virus with potent neutralization effect
146. Engineered trimeric ACE2 binds viral spike protein and locks it in “Three-up” conformation to potently inhibit SARS-CoV-2 infection
147. Quantitative Proteomic Analysis of Exosome Protein Content Changes Induced by Hepatitis B Virus in Huh-7 Cells Using SILAC Labeling and LC–MS/MS
148. Identification of natural recombination in duck hepatitis B virus
149. Selection of HBV preS1-binding penta-peptides by phage display
150. Recombinant Covalently Closed Circular Hepatitis B Virus DNA Induces Prolonged Viral Persistence in Immunocompetent Mice
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.